Antiviral compounds and methods for producing and using the same
Compounds of formula I and their salts provide effective treatment and prevention of viral infections in Paramyxoviridae, Pneumoviridae, Flaviviridae, Filoviridae, and Orthomyxoviridae families by targeting these viruses and reducing viral load, with enhanced metabolic resistance and broad species applicability.
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- GILEAD SCIENCES INC
- Filing Date
- 2026-02-06
- Publication Date
- 2026-06-09
AI Technical Summary
There is a need for effective compounds and methods to treat infections caused by viral families such as Paramyxoviridae, Pneumoviridae, Flaviviridae, Filoviridae, and Orthomyxoviridae, as existing treatments are inadequate.
Development of compounds of formula I and their pharmaceutically acceptable salts, which can be administered to prevent or treat viral infections by targeting these viral families, including pharmaceutical compositions and methods for administration.
The compounds effectively prevent or treat viral infections by reducing viral load and alleviating symptoms, with the potential for increased half-life and resistance to metabolism through deuterium substitution, and applicability to various animal species.
Smart Images

Figure 2026094177000001 
Figure 2026094177000002 
Figure 2026094177000003